Bioresp Technologies, Inc. — Department of Health and Human Services SBIR Phase I: NIDA

Description

Bioresp TechnologiesIncproposes development of RespiLifea new wearable device to to track physiologic data for early detection of opioid overdose and to relay data and the generated alerts to relevant caregivers for further interventionThe goal is to reduce the number opioids related deaths by early detection of overdoseOpioid epidemic death toll has quadrupled sinceAbout half of those deaths are due to prescription opioids and for the most part are unintentionalRespiLife tracks oxygen saturationrespiratory rateand pulse rate and based on a machine learning algorithm will determine changes from the baseline and correlation of those changes with changes in medicationsOur specific aims areProduction of five working prototypes with their algorithm to use in our validation studyA validation study to compare our data with a gold standard device and carry out statistical analysis for evaluation of agreement and accuracy Public health relevanceCurrently we in the midst of an opioid overdose epidemic that has resulted in a four fold increase in death rate since